Placing Update and TVR

RNS Number : 0568U

Angle PLC

08 October 2010

 



For immediate release

8 October 2010

ANGLE plc ('ANGLE' or the 'Company')

Placing Update and Total Voting Rights

ANGLE plc, which focuses on the commercialisation of technology and the development of technology-based industry, is pleased to announce the receipt of subscription funds pursuant to the Placing announced on 9 September. As a result, the Company has applied for the Subscription Shares to be admitted to trading on AIM on 13 October 2010 ("Admission").

For the purpose of the Financial Services Authority's Disclosure and Transparency Rules, the Company's total issued share capital following Admission will consist of 30,437,279 Ordinary Shares of 10 pence each, with one voting right per share. There are no shares held in treasury.

The total number of voting rights in the Company will therefore be 30,437,279.

The above figure of 30,437,279 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

For further information:

ANGLE plc	01483 685830
Andrew Newland, Chief Executive Ian Griffiths, Finance Director
Collins Stewart Europe Limited Stewart Wallace	0207 523 8350
Scott Harris Stephen Scott, James O'Shaughnessy, Harry Dee	0207 653 0030

Notes to Editors

ANGLE plc

Founded in 1994, ANGLE focuses on the commercialisation of technology and the development of technology-based industry. ANGLE creates, develops and advises technology businesses on its own behalf and for its clients. 

ANGLE's specialist Management services business provides support on a fee-for-service basis to major clients around the world involved in incubation, IP commercialisation, SME innovation and growth and the operation of science & technology parks.

ANGLE also owns a portfolio of company holdings with high growth potential in the medical and technology sectors.  These have been developed whilst subsidiaries of ANGLE using its proprietary Progeny® process.  ANGLE seeks to retain a substantial shareholding in these companies with a view to ongoing returns from dividend, milestone, royalty and capital returns.   

ANGLE's technology commercialisation skills are of increasing relevance as global economies focus on regeneration, innovation and value added components to their industries.  ANGLE's technology skills in IT and software, medical and life sciences, clean tech and renewable energies are directly relevant to major growth markets of the future and are marketed as specialised Management services. 

ANGLE is quoted on AIM (AGL.L); further information can be found on www.ANGLEplc.com

 

END

 

 

MSCUBVSRRVARRAA